Zobrazeno 1 - 10
of 26
pro vyhledávání: ''
Autor:
Danielle S. Bitterman, Miranda B. Lam, Nayan Lamba, Sana Raoof, Daniel Kim, Amandeep R. Mahal, Grace M. Lee, Nina N. Sanford, Harvey J. Mamon
Publikováno v:
Molecular and Clinical Oncology
There are few treatment guidelines for locally recurrent esophageal cancer after trimodality treatment (pre-operative chemoradiation followed by surgery) in patients with a poor performance status. The purpose of this single institutional, retrospect
Autor:
Lu Xie, Wei Guo, Kunkun Sun, Xin Liang, Xiaowei Li, Hongqing Zhuang, Xin Sun, Jie Xu, Jin Gu, Kuisheng Liu, Zuli Zhou, Yiming Wu
Publikováno v:
Oncology Letters
For osteosarcoma that progresses following first-line chemotherapy, prognosis remains poor although anti-angiogenesis tyrosine kinase inhibitors (TKIs) have been verified to prolong progression-free survival. Apatinib has led to positive responses in
Autor:
Justyna Wierzbicka, Michał A. Żmijewski, Agnieszka Rybarczyk, Andrzej Slominski, Anna Piotrowska, Robert C. Tuckey
Publikováno v:
International Journal of Oncology
Melanoma represents a significant challenge in cancer treatment due to the high drug resistance of melanomas and the patient mortality rate. This study presents data indicating that nanomolar concentrations of the hormonally active form of vitamin D,
Autor:
Yusuke Nakamura, Noriyuki Yamada, Ryo Takata, Toyomasa Katagiri, Tomohiko Matsuura, Hitoshi Zembutsu, Mitsugu Kanehira, Wataru Obara, Yoichiro Kato, Tamotsu Sugai, Renpei Kato, Tomoaki Fujioka, Kazuhiro Iwasaki
Publikováno v:
Oncology Letters
The present study established systems to predict the chemo-sensitivity of muscle invasive bladder cancer (MIBC) for neoadjuvant chemotherapy (NAC) with methotrexate, vinblastine, doxorubicin plus cisplatin (M-VAC) and carboplatin plus gemcitabine (Ca
The present study aimed to investigate the significance of the neutrophil to lymphocyte ratio (NLR) in peripheral blood of patients with small cell lung cancer (SCLC) when selecting a first-line treatment. A total of 73 patients with SCLC who had com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29a17a24deaa969f372c574341ee67ae
https://europepmc.org/articles/PMC6607396/
https://europepmc.org/articles/PMC6607396/
The aim of the present study was to evaluate the antitumor activity of drugs in phase II clinical trials for recurrent or refractory EWS. A systematic review was performed using clinical trials from four data sources: i) ClinicalTrials.gov; ii) PubMe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0e5c6603f827cf0e3fc68e9c4d0b024
https://europepmc.org/articles/PMC6540207/
https://europepmc.org/articles/PMC6540207/
Autor:
Yoshiro Nakahara, Shinya Harada, Masayuki Shirasawa, Noriyuki Masuda, Jiichiro Sasaki, Hideyuki Niwa, Yasuhiro Hiyoshi, Takahiro Ozawa, Seiichiro Kusuhara, Masashi Kasajima
Publikováno v:
Molecular and Clinical Oncology
Pegfilgrastim is a long-acting granulocyte colony-stimulating factor formulation that has been approved for the prevention of febrile neutropenia. We herein report a case of interstitial pneumonia following administration of pegfilgrastim. A 65-year-
Autor:
Xiaoai Zhao, Jin Yang, Le Wang, Mi Zhang, Lingxiao Zhang, Andi Zhao, Pan Li, Jiao Yang, Zhe Ling Chen
It is generally acknowledged that gastric cancer requires comprehensive treatment approaches to be adopted. For patients with human epidermal growth factor receptor-2 (HER2)-overexpressing gastric cancer, targeting HER2 with trastuzumab in first-line
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e5ca705e4771cbe21354b41069016d6
https://europepmc.org/articles/PMC6126328/
https://europepmc.org/articles/PMC6126328/
The present study describes the case of a 48-year-old man who was diagnosed with lung adenocarcinoma with an epidermal growth factor receptor (EGFR) 21 L858R mutation. The patient received surgery and adjuvant chemotherapy. When multiple lung metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6fa03e4a787fcc79460dd0b2eaa8731
https://europepmc.org/articles/PMC5840615/
https://europepmc.org/articles/PMC5840615/
It has previously been demonstrated that the intratumoral generation of the potent androgen dihydrotestosterone (DHT), contributes critically to the progression of prostate cancer and its castration-resistant form, castration-resistant prostate cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9487a487f132d87ae2c01a28a17e6b7c
https://europepmc.org/articles/PMC5769310/
https://europepmc.org/articles/PMC5769310/